Research ArticleClinical Studies

CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer

YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA and SOICHIRO ISHIHARA
Anticancer Research April 2022, 42 (4) 2033-2043; DOI: https://doi.org/10.21873/anticanres.15684

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer
YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA, SOICHIRO ISHIHARA
Anticancer Research Apr 2022, 42 (4) 2033-2043; DOI: 10.21873/anticanres.15684
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords